32 Biosciences, Inc.

CIK: 2020332DEIncorporated: 2023-06-05

Current Offering

$50,000
Target Amount
$1,235,000
Maximum Amount
2024-10-22
Deadline

Security Details

Type: Crowd SAFE (Simple Agreement for Future Equity)
Price per share: $1.00
Shares offered: 50,000+

Offering Costs

Cash commission: 6%
The Issuer shall pay the Intermediary the greater of (A) a fee of 6% of the dollar amount raised in the Offering or (B) a cash fee of $12,000.00. Additionally, the Issuer shall pay to the Intermediary a non-refundable onboarding fee of $5,000.00.
Equity compensation: 2%
The Intermediary will also receive compensation in the form of securities equal to one and one-half percent (1.5%) of the total number of the securities sold in the Offering.

Financial Reports

Offering via Republic

Offering History

As of 2024-06-24
Raising $50,000 -$1,235,000 via 50,000+ shares of crowd SAFE (Simple Agreement for Future Equity) at $1.00 per share
Deadline: 2024-10-22
As of 2024-10-09
Raising $50,000 -$618,000 via 50,000+ shares of crowd SAFE (Simple Agreement for Future Equity) at $1.00 per share
Deadline: 2024-12-20
Filing date2024-06-24
Current employees4
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$3,277
Cash equi prior fiscal year$0.00
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$0.00
Long term debt prior fiscal year$0.00
Net income most recent fiscal year$3,111
Net income prior fiscal year$0.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$116.00
Short term debt prior fiscal year$0.00
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$3,227
Total asset prior fiscal year$0.00

Company Information

Corporation
DE
2023-06-05

Latest Metrics

Employees4
Total Assets$3,227
Cash on Hand$3,277
Revenues$0.00
Net Income$3,111

Crowdfunding Portals

This company is raising funds through this portal